Copyright
©The Author(s) 2015.
World J Gastrointest Endosc. Jul 25, 2015; 7(9): 895-911
Published online Jul 25, 2015. doi: 10.4253/wjge.v7.i9.895
Published online Jul 25, 2015. doi: 10.4253/wjge.v7.i9.895
Medicine generic name | Route | Dose | Time to start sedation/analgesia (after iv application) | Sedation/analgesia duration | Repeating time and dose | Contraindications | Comments | Ref. |
Sedative/analgesic | ||||||||
Fentanyl | iv | 1–2 μg/kg (up to 50 μg) | 0.5 s | 20–40 min (30–60 min) | 3 min 1–1.25 μg/kg | Due to higher clearance younger children need frequent dosing | [38,40] | |
Ketamine | iv slowly over 1 min; other routes have less predictive effects and different dosing – see the discussion | 1–1.5 mg/kg | 1–5 min | 15 min | 10 min | Severe cardiovascular disease, malignant hypertension, CSF obstructive states (controversial), intraocular pressure pathology; previous psychotic illness, hyperthyroidism or thyroid medicine use; porphyria | A single enantiomer S(+); | [8,40-42] |
0.5 mg/kg | the anesthetic management of seriously ill hypovolemic patients, it may be the agent of choice for managing children and burned patients; low cost | |||||||
Meperidine | iv slowly over 1–2 min | 0.3–2 mg/kg | 3–6 min | 60–180 min | Simultaneous treatment with monoamine oxidase inhibitors | [38,43,44] | ||
Midazolam | iv slowly over 2–3 min; other routes have less predictive effects and different dosing | 0.05–0.1 mg/kg in < 5 yr (max. 0.6 mg/kg); in 6–12 yr 0.025–0.05 mg/kg (max.0.4 mg/kg); in older than 12 yr 2–2.5 mg (in total not per kg BW) | 2–3 min | 45–60 min | Repeating doses every 2–5 min until desired effect; in children 6 mo–5 yr total dose up to 0.6 mg/kg or max. 6 mg; in 6–12 yr total dose up to 0.4 mg/kg or max. 10 mg; in older than 12 yr additional boluses of 1 mg until desired sedation | Respiratory depression, hypotension | Rarely used as a sole sedative; might be used to sedate the frightened child before iv catheter placement; mostly combined with opioids; paradoxical irritation in 1%–5% of patients | [38-40] |
Nitrous oxide | Inhalation | Mostly the mixture of nitrous oxide (50%) and oxygen | 0.5–1 min | 5 min | Continuously or “on demand” | Pneumothorax, bowel obstruction, head injury, pregnancy | Its use limited to anaesthesiologists | [38,40,45] |
Propofol | iv | 2 mg/kg in infants and young children (younger than 3 yr); 1 mg/kg in children older than 3 yr | 1–2 min | 5–15 min | 1 mg/kg (infants and children up to 3 yr); 0.5 mg/kg (children older than 3 yr) to reach the desired sedation; may be continuously infused at 100 μg/kg per min and increasing the speed of infusion by 50 μg/kg per min for prolonged procedures | Egg or soy allergy | For additional medication to alleviate infusion pain see text; alfentanil but not fentanyl increases propofol blood level; in many countries the use is limited to anaesthesiologists | [38,40,46] |
Sevoflurane | Inhalation | Different concentrations according to the age | Duchenne’s muscular dystrophy, moderate to severe liver disease of unknown aetiology, history of malignant hyperthermia | Its use limited to anaesthesiologists | [47-49] | |||
Antagonists | ||||||||
Flumazenil | iv | 0.02 mg/kg (max. 1 mg) | 1–3 min | 30 min | 1 min; same dose | Chronic benzodiazepine use; ingestion of drugs that increase the risk for seizures development (e.g., cyclic antidepressants, cyclosporine, and others) | Due to its shorter duration of action than most of benzodiazepines (e.g., midazolam) repeated doses may be needed | [38,40] |
Naloxone | iv or i.m. | 0.1 mg/kg (max. 2 mg) | 2 min | 20–40 min | 2 min; same dose | Hypersensitivity only | Due to its shorter duration of action than most of opioids (e.g., fentanyl) repeated doses may be needed | [38,40] |
- Citation: Orel R, Brecelj J, Dias JA, Romano C, Barros F, Thomson M, Vandenplas Y. Review on sedation for gastrointestinal tract endoscopy in children by non-anesthesiologists. World J Gastrointest Endosc 2015; 7(9): 895-911
- URL: https://www.wjgnet.com/1948-5190/full/v7/i9/895.htm
- DOI: https://dx.doi.org/10.4253/wjge.v7.i9.895